Picture of Quantum Genomics SA logo

ALQGC — Quantum Genomics SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Quantum Genomics receives regulatory approval to start phase II trial in hypertension

Nov 17 (Reuters) - Quantum Genomics SA  ALQGC.PA : 
    * Receives all regulatory approvals to start its phase II 
clinical trial in hypertension 
 
Source text for Eikon:  ID:nACT37990  
Further company coverage:  ALQGC.PA  
 
 (Gdynia Newsroom: +48 58 698 39 20) 
 ((Gdynia.newsroom@thomsonreuters.com;)) 
 
Keywords: QUANTUMGENOMICSSA/BRIEF

Recent news on Quantum Genomics SA

See all news